Background: Patterns of symptom frequency and distress have not been examined long-term after heart transplantation, nor have predictors of long-term symptom frequency and distress. This report identified the most commonly reported and distressful symptoms long-term after transplantation, described patterns of symptom frequency and distress over time, and examined predictors of symptom frequency and distress at 5 and 10 years after heart transplantation.
After heart transplantation, heart failure symptoms are replaced by symptoms related to surgery, transplant complications, and immunosuppression. The literature contains reports of symptom frequency and distress within the first 5 years after transplant, [1] [2] [3] [4] [5] with some additional reports after 5 years post-transplant. 6 -8 Jalowiec et al 1 identified a decrease in distress related to heart failure symptoms and an increase in symptom distress related to immunosuppression from before to early after heart transplantation. Other researchers have described transplant-related symptoms in long-term survivors of surgery. 6 -8 Patterns of symptom frequency and distress have not been examined long-term after transplant, nor have predictors of long-term symptom frequency and distress. Therefore, the purposes of this report were to:
1. identify the most commonly reported and most distressful symptoms at 5 and 10 years after heart transplantation, 2. describe patterns of symptom frequency and distress from 5 to 10 years after transplantation, 3. describe differences in symptom frequency and distress by demographic and clinical variables at 5 and 10 years after transplantation, and 4. identify predictors of symptom frequency and distress at both 5 and 10 years after heart transplantation.
Our exploration of symptoms in long-term heart transplant recipients was guided by Spilker and Revicki's 9 model of quality of life, which demonstrates relationships among disease, treatments, and symptoms, and how they can influence domains of quality of life. Disease causes clinical symptoms, and treatment is directed at the underlying disease and symptom relief, recognizing that symptoms may also result from the treatment. Symptoms influence quality of life. We define a symptom as "a patient's perception of an abnormal physical, emotional, or cognitive state." 10 
METHODS Sample
Our sample includes participants from a prospective, multisite, longitudinal study of quality of life. Patients who participated in our study were drawn from a pool of 1,437 heart transplant recipients who received an allograft between July 1, 1990 , and June 30, 1999, at 4 medical centers across the United States. We have previously described our inclusion criteria, sample size (including characteristics of enrolled vs non-enrolled patients), and reasons for non-enrollment. 11 Our final sample size was 555 heart transplant recipients who were between 5 and 10 years after transplant and had completed our booklet of self-report instruments at one or more time periods.
Instruments and Procedures
For this report, we used the Heart Transplant Symptom Checklist. 1 This instrument was selected because our focus was on symptoms and their relationship with clinical variables. The 91-item instrument measures symptom frequency (yes/no) and symptom distress (0 ϭ not bothered at all and 3 ϭ very bothered). This tool has 6 sub-scales: cardiopulmonary, gastrointestinal, genitourinary, neurologic, dermatologic/soft tissue, and psychologic. The psychometric strength of this instrument has been previously reported. 1, 12 It demonstrated excellent content and construct validity and internal consistency reliability, and is acceptable for use in the heart transplant population.
Additional data were collected from the patient and medical records. Demographic data (age, gender, race, marital status, and education) were recorded by patient self-report. Clinical data were collected from the medical records and the Cardiac Transplant Research Database (CTRD), a voluntary heart transplant database in Birmingham, Alabama. Clinical data included etiology of heart failure, United Network for Organ Sharing (UNOS) status at time of transplantation, post-transplant New York Heart Association (NYHA) functional class, comorbidities and complications of immunosuppression (cardiovascular problems, diabetes, renal problems, gout, orthopedic problems, gastrointestinal problems, infection, malignancy, and psychological problems), complications of the transplant (acute rejection and cardiac allograft vasculopathy), post-transplant medications, and hospital readmissions.
Each of the 4 medical centers received separate Institutional Review Board (IRB) approvals for conduct of our study and participation in the CTRD. Patients who agreed to join our study were given booklets of questionnaires every 6 months (based on the anniversary of their transplant) between 5 and 10 years after transplantation. Clinical data were also collected every 6 months.
Statistics
Before final statistical analysis, preliminary data were analyzed using univariate and graphic methods to facilitate inspection and interpretation of data. Data error due to data entry oversight was appropriately cor- rected. The data for each year were summarized using descriptive statistics and plotted over time. The degree of association between post-transplant symptom frequency and distress was examined using Pearson correlations. Paired t-tests assessed change in symptom frequency and distress scores between 5 and 10 years after transplantation. Differences in symptom frequency and distress by demographics and clinical characteristics at 5 and 10 years were examined using 2-sample t-tests. Finally, generalized linear models were used to identify predictors of symptom frequency and distress at 5 and 10 years after heart transplantation. Significance was established at a level of ␣ ϭ 0.05. All statistical analyses were performed using SAS 9.1 software (SAS Inc, Cary, NC).
RESULTS

Descriptive Analyses
Demographic and clinical characteristics. Symptom frequency at 5 and 10 years after heart transplantation. The 30 most common symptoms at 5 and 10 years after transplantation are listed in Table 2 . Four of the five most frequent symptoms were memory problems, fatigue, easy bruising, cramps in the extremities, and difficulty in sexual performance. Over time, the mean scores for symptom frequency (overall and by sub-scale) declined then remained stable after 7 years (Table 3) . At 5 and 10 years after transplantation, women experienced significantly more overall symptoms than men (0.27 vs 0.22, p ϭ 0.04 and 0.26 vs 0.18, p ϭ 0.03. respectively). Further sub-scale analysis indicated that the differences were significant for only physical symptoms at 5 years (0.27 vs 0.22, p ϭ 0.04) and for both physical and psychological symptoms at 10 years (0.26 vs 0.19, p ϭ 0.05 and 0.25 vs 0.14, p ϭ 0.01, respectively).
Differences in mean scores for symptom frequency were also detected by clinical characteristics of patients at 5 and 10 years (Table 4) . Patients who had psychological problems reported having more overall symptoms than patients who reported no psychological problems at both 5 and 10 years (0.30 vs 0.21, p Ͻ 0.0001 and 0.26 vs 0.18, p ϭ 0.04, respectively). In addition, at 5 years after transplantation, patients with gastrointestinal problems and acute rejection reported more overall symptoms compared with patients without these problems (0.27 vs 0.22, p ϭ 0.03 and 0.25 vs 0.20, p ϭ 0.02, respectively); whereas at 10 years, patients who had infection reported higher symptom frequency scores than patients who did not (0.24 vs 0.16, p ϭ 0.009).
Symptom distress at 5 and 10 years after heart transplantation. The 30 most distressful symptoms at 5 and 10 years are listed in Table 5 . Similar to the most frequent symptoms, memory problems, fatigue, easy bruising, cramps in the extremities, and difficulty in sexual performance were the most distressful symptoms at both 5 and 10 years. Over time, symptom distress steadily declined ( Figure 2 ). Overall symptom distress, overall physical distress, and distress related to gastrointestinal symptoms and psychological symptoms were significantly less at 10 Differences in symptom distress were also revealed by demographic and clinical characteristics (Table 3) . Overall symptom distress was higher in younger vs older patients and less vs more educated patients at 5 years after transplantation (0.54 vs 0.46, p Ͻ 0.002 and 0.56 vs 0.0.48, p ϭ 0.0005, respectively). At 10 years, differences in overall symptom distress were detected by race (white, 0.54 vs non-white, 0.45; p ϭ 0.05) and marital status (not married, 0.54 vs married, 0.44; p ϭ 0.008). Patients who had no gout and had psychological problems reported more overall symptom distress than patients who had gout and had no psychological problems at 5 years after transplantation (0.52 vs 0.45, p ϭ 0.02 and 0.57 vs 0.49, p ϭ 0.001, respectively; Table 4 ).
Correlations between symptom frequency and distress at 5 and 10 years after heart transplantation. At 5 years after transplant, all correlations between symptom frequency and distress were significant and ranged from 0.16 to 0.36 (Table 6 ). All correlations at 10 years after transplantation were significant except for genitourinary symptoms. Significant correlations at 10 years were somewhat stronger and ranged from 0.26 to 0.44.
Multivariate Analyses
Four separate generalized linear models were used to identify predictors of symptom frequency and distress at 5 and 10 years after heart transplantation. Sixteen independent variables, including 5 demographic char- acteristics, 9 comorbidities and complications of immunosuppression, and 2 complications of transplantation were entered into each model. Significant predictors of lower symptom frequency at 5 years after heart transplantation were not having psychological problems and not having cardiac allograft vasculopathy, and together with all variables in the model, accounted for 17% variance in symptom frequency (Table 7) . At 10 years, not having psychological problems and not having infection were significant predictors of lower symptom frequency, and together with all variables in the model, explained 23% of variance (Table 7) .
Significant predictors of less symptom distress at 5 years after transplantation were having more than a high school education, having no psychological problems, and having gout; along with all variables in the model, these accounted for 20% of symptom distress (Table 8) . At 10 years, 23% of symptom distress was explained by all variables in the model, with only marriage being significantly related to decreased symptom distress (Table 8) .
DISCUSSION
The most frequently reported symptoms long-term after heart transplantation, at moderate rates of 50% to 65%, were fatigue, sexual dysfunction, memory problems, bruising, and cramps. They were also most frequently reported as distressful symptoms, but at significantly lower rates of 16% to 22%; however, the mean symptom distress scores were higher than the mean symptom frequency scores. Our findings are influenced by demographic and clinical factors, as revealed by univariate and multivariate analyses at different times long-term after transplantation. The rates of symptom frequency between 5 and 10 years are fairly similar to rates of symptom frequency reported by other researchers, 4, 5, 7, 8, 13 as are our rates of short-term and long-term symptom distress. [3] [4] [5] The prevalence of symptom frequency and distress suggests that clinicians need to assess for frequently occurring and bothersome symptoms short-term and long-term to provide targeted treatment strategies. Furthermore, our previous finding of a significant relationship between less overall symptom distress and better quality of life supports the importance of symptom management after transplantation. 14 Fatigue and sexual dysfunction were 2 of the most frequently reported and most distressful symptoms and merit further discussion. We have previously reported the relationship between fatigue and lower quality of life. 11 Reyes et al 6 reported high levels of fatigue in older women after heart transplantation, also noting that mean fatigue scores were higher in depressed vs non-depressed women. Fatigue was associated with anemia and renal insufficiency in their study. These findings provide evidence about the importance of assessing fatigue long-term after transplantation and incorporating both physiologic and psychological treatments, which may contribute to enhanced quality of life. Sexual dysfunction may also have both physiologic and psychological components. Similar to our findings, other researchers reported impairment in sexual function after transplantation. 4, 13, 15, 16 Medications, depression, body image, and changes in roles may contribute to sexual dysfunction. 16 Most reports also identified decreased libido after transplantation, similar to our results. 4, 13, 16 Our findings of sexual dysfunction, reported almost 2 decades after some of these articles, 4, 15, 16 suggest that this problem is still prevalent long-term after transplantation and requires follow-up.
In our multivariable models, marital status and educational level were the only demographic variables to achieve significance and were related to symptom distress. Previous reports have associated marriage after heart transplantation with better quality of life 11, 13 and decreased mortality. 17 The discovery in our study of a relationship between having a spouse and decreased symptom distress suggests that marriage may be a proxy for social support and/or social interaction and may moderate the symptom experience.
Education perhaps contributes to greater understanding of symptom occurrence and treatment, resulting in less symptom distress. Having more education is also related to being more satisfied with health and functioning between 5 and 10 years after heart transplantation.
11 However, we only measured level of overall education and not healthrelated education, which are different constructs. Understanding the relationships of marriage and education with symptom distress requires further exploration.
Clinical variables were also associated with symptom frequency and distress. The relationship between psychological problems and symptom frequency and distress long-term after heart transplantation is notable. We have previously described the relationship of depression with quality of life 11 and physical functional disability 18 at 5 to 10 years after heart transplantation. Researchers have also reported that psychological distress may continue or increase at Ն 5 years. 19 -22 Thus, long-term after heart transplant, psychological counseling remains an important therapeutic intervention.
Gout was also a significant predictor in our multivariable model for symptom distress at 5 years, but the relationship was not in the expected direction: More gout predicted less symptom distress. The direction of this relationship may have been influenced by other confounding factors and its fairly low incidence. In our previous reports, the relationship between gout and disability in ambulation approached significance at 5 years, 23 and gout was a significant predictor of satisfaction with health and functioning at 5 to 10 years after transplantation.
11
Treatment of gout and control of symptoms may explain the unanticipated direction of the relationship in our model. More research is needed.
Study limitations include our survey of long-term survivors of heart transplantation who volunteered to participate in our study, which may have contributed to underestimation of symptom frequency and distress. Of those who did not join the study, 14% indicated they were too sick to participate and perhaps had higher rates of symptoms and symptom distress. However, 12% of patients did not enroll because they were too busy and might have had lower rates of symptoms and symptom distress. Our sample was robust, drawn from 4 distinct geographic regions in the United States, which may attenuate these limitations.
Our questionnaire completion rate was approximately 70%. In addition, our comparisons of symptom frequency and distress at 5 and 10 years after heart transplantation were from 2 mostly independent, pooled samples. Only 11% of patients completed both 5-and 10-year surveys, which may have influenced our findings. However, we did not find any significant differences in demographic and clinical characteristics between the 2 cohorts of patients at 5 and 10 years after transplantation.
Another study limitation is that the questionnaire may not have listed all relevant post-transplant symptoms. However, the questionnaire included open-ended questions about other symptoms, which had low reported frequencies. In conclusion, overall symptom frequency is low and symptom distress is moderate long-term after heart transplantation. Furthermore, significant relationships exist between both demographic and clinical variables and symptom frequency and distress. Identification of the most common and bothersome symptoms after heart transplantation provides clinicians with important information on which a plan of care can be developed. 
